October « 2013 « Science and Enterprise

High Speed Internet in Cars Found Distracting to Drivers

By Alan, on October 17th, 2013%

(A. Kotok)

Psychologists and engineers at University of Toronto in Ontario, Canada found adding high speed Internet connections to cars creates potential distraction risks to drivers, even when used with hands-free voice-controlled devices. The team led by Toronto psychologist Ian Spence published its findings in the September-October 2013 issue of the journal Applied . . . → Read More: High Speed Internet in Cars Found Distracting to Drivers

Super-Antioxidant Developed from Catalyst Nanoparticles

By Alan, on October 16th, 2013%

Vicki Colvin (Rice University)

Chemists and bioengineers at Rice University in Houston developed an antioxidant from an element used in catalytic converters that they found to be many times more powerful than antioxidants now on the market. The team from the labs of Vicki Colvin and Laura Segatori published their findings earlier this month . . . → Read More: Super-Antioxidant Developed from Catalyst Nanoparticles

Genetic-Based Antibiotic Found Effective in Lab Tests

By Alan, on October 15th, 2013%

Acinetobacter baumanii, one of the strains tested with PPMOs by the research team ( F. Silveira, NIH)

Researchers at Oregon State University, University of Texas Southwestern Medical Center, and the biotechnology company Sarepta Therapeutics tested in lab mice an antibiotic developed from synthetic genetic material that kills bacteria resistant to traditional antibiotics. Their findings . . . → Read More: Genetic-Based Antibiotic Found Effective in Lab Tests

Evogene, DuPont Pioneer Extend Biotech Soybean Partnership

By Alan, on October 15th, 2013%

(Kevin Dooley/Flickr)

Evogene Ltd, a biotechnology company in Rehovot, Israel is extending its collaboration with the Pioneer subsidiary of the U.S. chemical company DuPont to develop soybean varieties resistant to Asian soybean rust, a damaging fungus to soybean plants. The agreement adds one year to the partnership between the two companies, but financial . . . → Read More: Evogene, DuPont Pioneer Extend Biotech Soybean Partnership

Protocols Linking Underwater Devices to Internet Proposed

By Alan, on October 14th, 2013%

Tommaso Melodia (University at Buffalo)

Engineers from University at Buffalo in New York are proposing a common set of wireless protocols for connecting underwater sensors, like those detecting tsunamis, to the land-based Internet. Electrical engineering professor Tommaso Melodia and graduate student Yifan Sun will present their proposal next month at ACM’s International Conference . . . → Read More: Protocols Linking Underwater Devices to Internet Proposed

St. Jude Medical Acquires Leadless Pacemaker Developer

By Alan, on October 14th, 2013%

Nanostim pacemaker compared in size to Euro coin (St. Jude Medical Inc.)

St. Jude Medical, a medical device company in St. Paul, Minnesota, is acquiring Nanostim Inc., a developer of self-contained leadless heart pacemakers in Sunnyvale, California. Shareholders in the privately owned Nanostim can receive up to $188.5 million in upfront cash and . . . → Read More: St. Jude Medical Acquires Leadless Pacemaker Developer

Fortified Hydrogel Cartilage Regeneration Technique Devised

By Alan, on October 12th, 2013%

(NASA.gov)

Researchers at École polytechnique fédérale de Lausanne (EPFL) in Switzerland developed a method for delivering regenerative drugs at the right place and time to repair damaged cartilage tissue. The team from EPFL’s biomechanical orthopedics and polymers labs published advance results this week of their proof-of-concept tests in the journal Biomaterials (paid subscription . . . → Read More: Fortified Hydrogel Cartilage Regeneration Technique Devised

On the Road Again …

By Alan, on October 10th, 2013%

(TSA.gov)

We will be travelling over the next two days, so Science and Enterprise will not be posting items today or tomorrow. We will be back to our regular posting schedule on Monday 14 October.

* * *

Clinical Trial of ALS Stem Cell Therapy Begins Treatments

By Alan, on October 9th, 2013%

Eva Feldman (University of Michigan)

The first two of up to 15 patients received their first injections of stem cells to treat amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, in an intermediate-stage clinical trial at University of Michigan in Ann Arbor and Emory University in Atlanta. The study is testing stem cell treatments . . . → Read More: Clinical Trial of ALS Stem Cell Therapy Begins Treatments

Genome Analysis Via Mobile App, Web Site in Development

By Alan, on October 9th, 2013%

(Genome.gov)

A genomics lab at Tel Aviv University in Israel is developing a system making it possible to upload a person’s whole genome and get results analyzed through a mobile app. Tel Aviv graduate students Ofer Isakov and Gershon Celniker in the lab of geneticist Noam Shomron are writing the software that they . . . → Read More: Genome Analysis Via Mobile App, Web Site in Development

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise